125 related articles for article (PubMed ID: 30123940)
1. Structure-based design, synthesis and anticancer effect of cyclic Smac-polyarginine peptides.
Khalily MP; Gerekçi S; Güleç EA; Özen C; Özçubukçu S
Amino Acids; 2018 Nov; 50(11):1607-1616. PubMed ID: 30123940
[TBL] [Abstract][Full Text] [Related]
2. Chemosensitization of Prostate Carcinoma Cells with a Receptor-directed Smac Conjugate.
Sturzu A; Sheikh S; Echner H; Deeg M; Nägele T; Weidenmaier C; Schwentner C; Horger M; Ernemann U; Heckl S
Med Chem; 2016; 12(5):412-8. PubMed ID: 26558373
[TBL] [Abstract][Full Text] [Related]
3. IAP Proteins Antagonist: An Introduction and Chemistry of Smac Mimetics under Clinical Development.
Ali R; Singh S; Haq W
Curr Med Chem; 2018; 25(31):3768-3795. PubMed ID: 29532750
[TBL] [Abstract][Full Text] [Related]
4. Design of small-molecule peptidic and nonpeptidic Smac mimetics.
Sun H; Nikolovska-Coleska Z; Yang CY; Qian D; Lu J; Qiu S; Bai L; Peng Y; Cai Q; Wang S
Acc Chem Res; 2008 Oct; 41(10):1264-77. PubMed ID: 18937395
[TBL] [Abstract][Full Text] [Related]
5. Interaction of SMAC with a survivin-derived peptide alters essential cancer hallmarks: Tumor growth, inflammation, and immunosuppression.
Santhanam M; Kumar Pandey S; Shteinfer-Kuzmine A; Paul A; Abusiam N; Zalk R; Shoshan-Barmatz V
Mol Ther; 2024 Jun; 32(6):1934-1955. PubMed ID: 38582961
[TBL] [Abstract][Full Text] [Related]
6. Predominant suppression of apoptosome by inhibitor of apoptosis protein in non-small cell lung cancer H460 cells: therapeutic effect of a novel polyarginine-conjugated Smac peptide.
Yang L; Mashima T; Sato S; Mochizuki M; Sakamoto H; Yamori T; Oh-Hara T; Tsuruo T
Cancer Res; 2003 Feb; 63(4):831-7. PubMed ID: 12591734
[TBL] [Abstract][Full Text] [Related]
7. Design of small-molecule Smac mimetics as IAP antagonists.
Wang S
Curr Top Microbiol Immunol; 2011; 348():89-113. PubMed ID: 21072626
[TBL] [Abstract][Full Text] [Related]
8. Solid phase synthesis of Smac/DIABLO-derived peptides using a 'Safety-Catch' resin: identification of potent XIAP BIR3 antagonists.
Elsawy MA; Martin L; Tikhonova IG; Walker B
Bioorg Med Chem; 2013 Sep; 21(17):5004-11. PubMed ID: 23886811
[TBL] [Abstract][Full Text] [Related]
9. Pharmacology of smac mimetics; chemotype differentiation based on physical association with caspase regulators and cellular transport.
Talbott RL; Borzilleri RM; Chaudhry C; Fargnoli J; Shen H; Fairchild C; Barnhart B; Ortega M; McDonagh TE; Vuppugalla R; Vite GD; Hunt JT; Gottardis M; Naglich JG
Exp Cell Res; 2015 Nov; 338(2):251-60. PubMed ID: 26302264
[TBL] [Abstract][Full Text] [Related]
10. X-linked inhibitor regulating TRAIL-induced apoptosis in chemoresistant human primary glioblastoma cells.
Roa WH; Chen H; Fulton D; Gulavita S; Shaw A; Th'ng J; Farr-Jones M; Moore R; Petruk K
Clin Invest Med; 2003 Oct; 26(5):231-42. PubMed ID: 14596484
[TBL] [Abstract][Full Text] [Related]
11. The SMAC mimetic BV6 induces cell death and sensitizes different cell lines to TNF-α and TRAIL-induced apoptosis.
El-Mesery M; Shaker ME; Elgaml A
Exp Biol Med (Maywood); 2016 Dec; 241(18):2015-2022. PubMed ID: 27465142
[TBL] [Abstract][Full Text] [Related]
12. The synergistic effect of chimeras consisting of N-terminal smac and modified KLA peptides in inducing apoptosis in breast cancer cell lines.
Tavakoli S; Firoozpour L; Davoodi J
Biochem Biophys Res Commun; 2023 May; 655():138-144. PubMed ID: 36934589
[TBL] [Abstract][Full Text] [Related]
13. Apoptosis-inducing peptide loaded in PLGA nanoparticles induces anti-tumor effects in vivo.
Priwitaningrum DL; Jentsch J; Bansal R; Rahimian S; Storm G; Hennink WE; Prakash J
Int J Pharm; 2020 Jul; 585():119535. PubMed ID: 32534162
[TBL] [Abstract][Full Text] [Related]
14. Rapid induction of IAP family proteins and Smac/DIABLO expression after proapoptotic stimulation with doxorubicin in RPMI 8226 multiple myeloma cells.
Abe S; Hasegawa M; Yamamoto K; Kurata M; Nakagawa Y; Suzuki K; Takizawa T; Kitagawa M
Exp Mol Pathol; 2007 Dec; 83(3):405-12. PubMed ID: 17521628
[TBL] [Abstract][Full Text] [Related]
15. A novel polyarginine containing Smac peptide conjugate that mediates cell death in tumor and healthy cells.
Heckl S; Sturzu A; Regenbogen M; Beck A; Feil G; Gharabaghi A; Echner H
Med Chem; 2008 Jul; 4(4):348-54. PubMed ID: 18673146
[TBL] [Abstract][Full Text] [Related]
16. Apoptosis-associated release of Smac/DIABLO from mitochondria requires active caspases and is blocked by Bcl-2.
Adrain C; Creagh EM; Martin SJ
EMBO J; 2001 Dec; 20(23):6627-36. PubMed ID: 11726499
[TBL] [Abstract][Full Text] [Related]
17. Endogenously released Smac is insufficient to mediate cell death of human lung carcinoma in response to etoposide.
Bartling B; Lewensohn R; Zhivotovsky B
Exp Cell Res; 2004 Aug; 298(1):83-95. PubMed ID: 15242764
[TBL] [Abstract][Full Text] [Related]
18. Smac mimetics as new cancer therapeutics.
Chen DJ; Huerta S
Anticancer Drugs; 2009 Sep; 20(8):646-58. PubMed ID: 19550293
[TBL] [Abstract][Full Text] [Related]
19. Cyclopeptide Smac mimetics as antagonists of IAP proteins.
Sun H; Liu L; Lu J; Qiu S; Yang CY; Yi H; Wang S
Bioorg Med Chem Lett; 2010 May; 20(10):3043-6. PubMed ID: 20443226
[TBL] [Abstract][Full Text] [Related]
20. A small molecule Smac mimic potentiates TRAIL-mediated cell death of ovarian cancer cells.
Petrucci E; Pasquini L; Petronelli A; Saulle E; Mariani G; Riccioni R; Biffoni M; Ferretti G; Benedetti-Panici P; Cognetti F; Scambia G; Humphreys R; Peschle C; Testa U
Gynecol Oncol; 2007 May; 105(2):481-92. PubMed ID: 17292950
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
